Laurence J. Miller, MD
Laurence J. Miller, MD is director for research at Mayo Clinic and Director of the Mayo Clinic Cancer Center in Arizona. He received his Bachelors Degree with high distinction from Pennsylvania State University in 1971. Dr. Miller attended the Jefferson Medical College receiving his M.D. and the University of Minnesota for his M.S. in Medicine. Following his internal medicine internship at Thomas Jefferson University, he then completed both his residency in internal medicine and fellowship in gastroenterology at Mayo Graduate School of Medicine. Pursuing his interest in Cell Biology, Dr. Miller continued his post-doctoral research training at Yale University School of Medicine.

Dr. Miller is recognized as an expert in pancreatic disease, including pancreatic cancer. His research group is using molecular genetic techniques o try to identify cancer at an earlier stage when it has the best chance of being cured by surgery.

James Moser, M.D.
Dr. Moser directs active research projects in both basic science and patient-centered research at the University of Pittsburgh. Dr. Moser is the Principal Investigator of the Biliary Physiology Laboratory within the Departments of Surgery and Cell Biology, and his laboratory is funded by the Natioanl Institute of Health. His basic research lab studies the biology of the epithelial lining of the gall bladder and bile ducts. Dr. Moser�s clinical research involves novel forms of chemotherapy and radiation for invasive tumors of the pancreas. He directs the clinical research project for patients with locally advanced tumors of the pancreas within the Division of Surgical Oncology and the Pittsburgh Cancer Institute. This clinical research project is funded by Pharmacia and studies preoperative irinotecan, celecoxib, and radiation therapy as a method for improving the care of patients with pancreas cancer. This clinical research project also investigates tumor tissue from treated patients in an effort to identify genetic factors wich may predict improved survival following preoperative chemotherapy and radiation.

Donald Northfelt, M.D.
Associate Professor of Medicine, College of Medicine, Mayo Clinic Consultant, Division of Hematology/Oncology, Mayo Clinic Arizona clinical and research interests in phase 1 clinical trials, oncology new drug development.

Allyson J. Ocean, M.D.
Dr. Ocean is a medical oncologist and attending physician in gastrointestinal oncology, Solid Tumor Division, at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Assistant Professor of Medicine at the Weill Medical College of Cornell University; and medical oncologist at The Jay Monahan Center for Gastrointestinal Health.

Board certified in internal medicine, hematology, and medical oncology, Dr. Ocean�s primary interest is in the biology and treatment of gastrointestinal malignancies, such as colorectal, pancreatic, stomach, biliary, and liver cancers. In her clinical practice, Dr. Ocean believes in the provision not only of state-of-the art treatment for her patients and their families, but also in a comprehensive, compassionate, multidisciplinary approach to their care and support.

Dr. Ocean graduated with honors from the Tufts University School of Medicine and completed residency in internal medicine at New York-Presbyterian/Weill Cornell Medical Center. Dr. Ocean was chief fellow during her fellowship in hematology and medical oncology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Ocean is the author of numerous peer-reviewed articles and abstracts and is an active member of several professional societies, including the American Society of Clinical Oncology, American Society of Hematology, and American Association for Cancer Research.